Clinical Reasoning and Priority Setting in Anaphylaxis
When a patient presents with a severe allergic reaction after a known trigger such as shellfish ingestion, the clinical picture is consistent with
anaphylaxis. The defining characteristic of anaphylaxis is a rapid-onset, potentially fatal systemic hypersensitivity reaction involving airway, breathing, or circulatory compromise
[1]. The pathophysiological cascade is driven by mast-cell activation, predominantly via IgE-mediated pathways, which triggers the release of potent vasoactive mediators like histamine and tryptase
[1]. This results in a profound increase in vascular permeability and smooth muscle contraction, leading to the classic manifestations of airway edema, bronchoconstriction, and distributive shock.
The critical priority in the initial management of anaphylaxis is to halt this mediator-driven cascade and reverse its life-threatening effects.
Epinephrine is the first-line pharmacological intervention because it directly counteracts the underlying pathophysiology. Its alpha-1 adrenergic effects cause vasoconstriction, which reverses peripheral vasodilation and reduces mucosal edema in the airway. Its beta-2 adrenergic effects cause bronchodilation and also suppress further mediator release from mast cells and basophils
[1]. Delayed administration of epinephrine is a primary driver of preventable deaths in anaphylaxis, making its prompt intramuscular injection the highest-priority nursing action
[2].
The other listed interventions are important but are secondary to the immediate administration of epinephrine. While the patient may require supplemental oxygen, the airway obstruction and shock in anaphylaxis are primarily due to tissue edema and vasodilation, not a primary oxygenation deficit that oxygen alone can correct. Establishing IV access is crucial for fluid resuscitation to manage the distributive shock component, but this should not delay the life-saving injection of epinephrine into the anterolateral thigh. Preparing for intubation anticipates a potential deterioration, but epinephrine can often reverse laryngeal edema and bronchospasm quickly enough to avert the need for an invasive airway. The sequence of priorities is clear: the evidence consistently emphasizes that epinephrine administration is the cornerstone of immediate management and must not be postponed
[2][3].
The correct first intervention is to administer
epinephrine 1:1000 intramuscularly at a dose of
0.3 to 0.5 mg into the mid-outer thigh, with the dose repeated every
5 to 15 minutes if there is no clinical improvement
[3]. This action directly addresses the rapid hemodynamic compromise that defines severe anaphylaxis and has the greatest impact on patient survival.
References (research sources)
- [1]
Overview of allergic disease: Anaphylaxis - WAO White Book on Allergy 2026 - 2.11.Research articleCardona V. (2026) · DOI: 10.1016/j.waojou.2026.101338
- [2]
Acute Allergic Reactions and Severe Anaphylaxis: Underlying Causes, Management Strategies, and Future Directions.Research articleEllorin A, Agrawal DK. (2026)
- [3]
Novelties in the pragmatic management of anaphylaxis in pediatric age.Research articleMarseglia GL, Tosca MA, Miraglia Del Giudice M, Manti S, Ciprandi G, Licari A. (2026) · DOI: 10.1007/s00431-026-07147-3